Clincosm LogoSign in Get a demo

Dyslipidemia

Showing 51 - 75 of 348
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension, Dyslipidemia Trial in United States (Amlodipine/Atorvastatin)

Completed
  • Hypertension
  • Dyslipidemia
  • Birmingham, Alabama
  • +105 more
Jan 26, 2021

Insulin Resistance, Type 2 Diabetes, Metabolic Syndrome Trial in Berkeley, San Francisco (Diet)

Completed
  • Insulin Resistance
  • +4 more
  • Diet
  • Berkeley, California
  • +1 more
Dec 22, 2020

Dyslipidemia, Healthy Volunteers Trial in Miramar (TAP311)

Completed
  • Dyslipidemia
  • Healthy Volunteers
  • Miramar, Florida
    Novartis Investigative Site
Dec 17, 2020

Dyslipidemia Trial in Glendale, Baltimore (AZD6615, Placebo)

Terminated
  • Dyslipidemia
  • Glendale, California
  • +1 more
Dec 11, 2020

Research With PCSK9 Inhibition in High Risk Coronary Artery

Unknown status
  • Dyslipidemia
  • High Risk Coronary Artery Disease
  • Beijing, Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Dec 1, 2020

Cardiovascular Disease, Dyslipidemia, Insulin Resistance Trial in Berkeley (High saturated fat red meat diet, High saturated fat

Completed
  • Cardiovascular Disease
  • +3 more
  • High saturated fat red meat diet
  • +5 more
  • Berkeley, California
    Cholesterol Research Center, Children's Hospital Research Instit
Nov 20, 2020

Type 1 Diabetes, Dyslipidemia Trial in Aurora (Simvastatin, Ezetimibe/Simvastatin)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Dyslipidemia
  • Aurora, Colorado
    Barbara Davis Center for Childhood Diabetes
Oct 19, 2020

Dyslipidemia Trial in Philadelphia (ER Niacin Oral Fat Challenge, IR Niacin Oral Fat Challenge, Placebo Oral Fat Challenge)

Completed
  • Dyslipidemia
  • ER Niacin Oral Fat Challenge
  • +2 more
  • Philadelphia, Pennsylvania
  • +1 more
Jul 8, 2020

Important Food Sources of Sugars on Cardiometabolic Risk Factors

Unknown status
  • Dyslipidemia
  • +7 more
  • Fructose-containing Sugars
  • Toronto, Ontario, Canada
    The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
Jun 23, 2020

Cardiovascular Diseases, Hypercholesterolemia, Dyslipidemia Trial in Oslo (Information on high risk factor levels and lifestyle

Unknown status
Has Results
  • Cardiovascular Diseases
  • +4 more
  • Information on high risk factor levels and lifestyle advice
  • +2 more
  • Oslo, P.B. 1046 Blinderen, Norway
    University of Oslo
Apr 23, 2020

HIV Reverse Cholesterol Transport Study

Unknown status
  • HIV
  • Dyslipidemia
    • London, United Kingdom
      Chelsea & Westminster Hospital
    Mar 24, 2020

    Dyslipidemia Trial in Chicago (LCP-AtorFen)

    Completed
    Has Results
    • Dyslipidemia
    • Chicago, Illinois
      Radiant Research, 515 N State St, Suite 2700
    Mar 2, 2020

    Hypertension, Insulin Resistance, Dyslipidemia Trial in Stanford (Telmisartan)

    Terminated
    • Hypertension
    • +2 more
    • Stanford, California
      Stanford Medical Center
    Mar 16, 2020

    Dyslipidemia Trial in Chicago (LCP-AtorFen, atorvastatin, fenofibrate)

    Completed
    Has Results
    • Dyslipidemia
    • Chicago, Illinois
      Radiant Research, 515 N State Street, Suite 2700
    Feb 4, 2020

    Colesevelam, Lipids And Sugars, South Asian Canadian Trial

    Completed
    • Dyslipidemia
      • Brampton, Ontario, Canada
        Dr. Milan Gupta,MD
      Jan 22, 2020

      Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada

      Completed
      • Dyslipidemia
      • survey
      • (no location specified)
      Jan 22, 2020

      Hypercholesterolemia, Dyslipidemia Trial in Brazil (Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10

      Completed
      Has Results
      • Hypercholesterolemia
      • Dyslipidemia
      • Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.
      • Simvastatin 20 mg + Ezetimibe 10 mg and Simvastatin 40 mg + Ezetimibe 10 mg, according to clinical evaluation.
      • Fortaleza, Ceará, Brazil
      • +6 more
      Jan 20, 2020

      Fenofibrate and Pharmacogenetic Impact in Dyslipidemia

      Completed
      • Dyslipidemia
      • Minneapolis, Minnesota
        University of Minnesota
      Jan 9, 2020

      Dyslipidemia Trial in United States (Placebo, Pravastatin, Dalcetrapib)

      Completed
      Has Results
      • Dyslipidemia
      • Placebo
      • +2 more
      • Mobile, Alabama
      • +32 more
      Dec 13, 2019

      Atherosclerosis, Diabetes, Obesity Trial run by the NHLBI (Exercise, Weight Loss)

      Completed
      • Atherosclerosis
      • +4 more
      • Exercise
      • Weight Loss
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 14, 2019

      Obesity, Insulin Resistance, Insulin Sensitivity Trial in Augusta (Placebo-Control, Low-Dose Vitamin K2 (menaquinone-7; 45

      Unknown status
      • Obesity
      • +5 more
      • Placebo-Control
      • +2 more
      • Augusta, Georgia
        Medical College of Georgia; Augusta University
      Nov 18, 2019

      Hypertension, Dyslipidemia Trial (Viena II 160/10, Viena II 190/10, Viena II 160/12)

      Withdrawn
      • Hypertension
      • Dyslipidemia
      • Viena II 160/10
      • +3 more
      • (no location specified)
      Oct 14, 2019

      Type 2 Diabetes, Dyslipidemia Trial (Metformin, Placebo)

      Completed
      Has Results
      • Type 2 Diabetes
      • Dyslipidemia
      • (no location specified)
      Sep 24, 2019

      Type 2 Diabetes, Insulin Resistance, Dyslipidemia Trial in Copenhagen (High carbohydrate overfeeding, Exercise, Normal physical

      Completed
      • Type 2 Diabetes Mellitus
      • +2 more
      • High carbohydrate overfeeding
      • +2 more
      • Copenhagen, Capital Region, Denmark
        Rigshospitalet, Denmark
      Sep 3, 2019

      The Hellenic Postprandial Lipemia Study (HPLS)

      Completed
      • Coronary Heart Disease
      • Dyslipidemia
        • Athens, Greece
          Onassion Cardiology Hospital
        Aug 28, 2019